Melanoma

Melanoma is skin cancer that begins in skin melanocytes, and is the most deadly form of skin cancer; 1 person dies of melanoma every hour. In the U.S. the cost of melanoma treatment is $3.3B/year. The risk of melanoma is lower in darkly pigmented skin.

 

Current Melanoma Standard of Care – Metastatic (Stage IV) Melanoma

Immunotherapy: Checkpoint inhibitors – like anti-PD-1 and anti-CTLA4 – are widely used to take the brakes off the immune system so that the patients own white blood cells can target and kill melanoma tumor cells.